Abnormal priming of CD4(+) T cells by dendritic cells expressing hepatitis C virus core and E1 proteins.
about
Generation of immune responses against hepatitis C virus by dendritic cells containing NS5 protein-coated microparticlesDendritic Cells in HIV-1 and HCV Infection: Can They Help Win the Battle?Role of the asialoglycoprotein receptor in binding and entry of hepatitis C virus structural proteins in cultured human hepatocytes.Dendritic Cell Function during Chronic Hepatitis C Virus and Human Immunodeficiency Virus Type 1 InfectionHepatitis C Virus Structural Proteins Impair Dendritic Cell Maturation and Inhibit In Vivo Induction of Cellular Immune ResponsesOncostatin M Enhances the Antiviral Effects of Type I Interferon and Activates Immunostimulatory Functions in Liver Epithelial CellsDifferential Effects of Hepatitis C Virus JFH1 on Human Myeloid and Plasmacytoid Dendritic CellsDirect binding of hepatitis C virus core to gC1qR on CD4+ and CD8+ T cells leads to impaired activation of Lck and Akt.Blockade of PD-1/B7-H1 interaction restores effector CD8+ T cell responses in a hepatitis C virus core murine modelClinical responders to antiviral therapy of chronic HCV infection show elevated antiviral CD4+ and CD8+ T-cell responses.Expression of hepatitis C virus core protein in hepatocytes does not modulate proliferation or apoptosis of CD8+ T cells.Virus-related liver cirrhosis: molecular basis and therapeutic options.Improved dendritic cell-based immunization against hepatitis C virus using peptide inhibitors of interleukin 10.The wild-type hepatitis C virus core inhibits initiation of antigen-specific T- and B-cell immune responses in BALB/c miceInhibition of the HCV core protein on the immune response to HBV surface antigen and on HBV gene expression and replication in vivo.Induction of hepatitis C virus-specific cytotoxic T and B cell responses by dendritic cells expressing a modified antigen targeting receptor.Viral interactions with B-cells contribute to increased regulatory T-cells during chronic HCV infection.Vaccination with dendritic cells pulsed with hepatitis C pseudo particles induces specific immune responses in mice.Differential dysfunction in dendritic cell subsets during chronic HCV infection.Prospects for dendritic cell vaccination in persistent infection with hepatitis C virusA self-adjuvanting lipopeptide-based vaccine candidate for the treatment of hepatitis C virus infectionHost and viral factors contributing to CD8+ T cell failure in hepatitis C virus infectionDendritic cells in viral pathogenesis: protective or defective?Monocyte derived dendritic cells retain their functional capacity in patients following infection with hepatitis C virus.Functionality of the immune system in patients with chronic hepatitis C: trial by superinfections and vaccinations.Cells as vehicles for therapeutic genes to treat liver diseases.Immune responses during acute and chronic infection with hepatitis C virus.Adaptive immune responses to hepatitis C virus: from viral immunobiology to a vaccine.Dendritic cells in hepatitis C infection: can they (help) win the battle?Different aspects of CD4 T cells that lead to viral clearance or persistence of HCV infection.Virus-Specific Cellular Response in Hepatitis C Virus Infection.A divergent population of autoantigen-responsive CD4+ T cells in infants prior to β cell autoimmunity.Hepatitis B reactivation during or after direct acting antiviral therapy - implication for susceptible individuals.Immune modulation by the hepatitis C virus core protein.Memory T-cell-mediated immune responses specific to an alternative core protein in hepatitis C virus infection.Thymosin Alpha-1 in Combination with Pegylated Interferon and Ribavirin in Chronic Hepatitis C Patients Who have Failed to Prior Pegylated Interferon and Ribavirin Treatment.Lack of phenotypic and functional impairment in dendritic cells from chimpanzees chronically infected with hepatitis C virus.Hepatitis C virus modulates human monocyte-derived dendritic cellsNew antiviral therapies for hepatitis C.Characterization of T-cell responses against immunodominant epitopes from hepatitis C virus E2 and NS4a proteins.
P2860
Q24652467-64A888C1-1A0C-4009-ADF3-CA85C0ADE638Q27010312-8003CA67-F07B-4790-A923-1174B08B04C8Q27473066-E698B450-9E7C-4DB6-BC60-5CB40941FEBEQ27481412-263BEFAF-28A3-4DC5-8BBD-122CEFEFF095Q27485419-DCFBA8D6-E1C5-4842-8397-B9FC5F0DF213Q27488206-9045EB14-A9D6-4975-B827-8CC181965C10Q27488392-5F819E22-D9F8-4862-94C5-B7E176ECB449Q30433630-66629DC8-14F1-4AD5-B6BC-329BCE3122A2Q30435498-6129DEDA-0C37-49FA-ACA6-188CCC9A8B83Q33282312-7061BFCD-6E5E-4EF1-92D7-9EEF795BE24AQ33607229-2ADA886E-575E-4C6D-81D6-CD54271DE493Q33718267-E9E626E3-D9F6-4162-BC00-36A55BA3F87BQ33770890-226076C7-FDA4-4195-9629-C0A7814629FEQ33962697-9508A085-EA57-4AF2-BC1F-06EF7BEAF6BCQ34425267-D6A8C988-63F4-4A40-834B-576E5AB2779EQ34605812-E1DE78C3-3C64-4F5D-87BD-25D0FE4B53EFQ34756691-90DD1186-A7B7-4E5B-B4B6-90C040EE59A3Q35776114-28D75F6C-47C4-4D9D-BC45-9ADC91EB7457Q35783178-A05280C5-4EBF-4057-B9DE-6393CEA30B95Q35784239-8BBE5DAF-ACFC-4C07-9BE4-85D35E449C2DQ35920476-1D00A72E-941F-4667-BD0E-6B1A7D81CCFBQ36179703-A8AA7297-9417-4E8B-B895-08CC7A8D4EB5Q36207868-5EB7BBC5-9D0A-4777-B32F-7EF2CAE12F45Q36499634-4CF1E9CB-C241-4D12-A1B2-38461DE419B2Q36899068-D55A8BF1-F2DE-47F2-85D6-DACEADAEE39BQ37127248-2F399318-DBEF-4488-B7D2-79693527276EQ37178225-2AB6E379-0A89-4009-B857-90BC0D1CE078Q37309244-9F4D1439-C467-4C50-B31C-254DB6FA6B0BQ37843841-83C3F829-5F8C-4553-B086-B81076A99978Q38552122-9B35CBEA-43B6-4336-9429-C0B517A3D1DCQ38597605-D0F51CC4-3F4F-4BC0-A6F5-CC649FD65BDFQ38754420-F5269DE1-381E-47F8-90AC-BF955C2B410FQ38805093-F533D81B-6BF1-4904-92C5-753ECEAEFA29Q39090584-9E09462E-17C6-4475-A808-7EEC6D88F3B3Q39991596-C55D06AF-BEC5-4AE3-837C-B897ECBB8386Q40608137-9E95E8A2-6F67-4148-82EE-0F72DA6E4827Q40886985-BA5CA4C2-DE4F-4876-A538-0B280C904147Q41785343-27506949-C475-4B2F-A89E-1520AF17E22BQ42988183-DAB27EE2-2B36-454B-BA90-A923170807C6Q42997235-E54970CA-F552-46A2-83B8-3A6E1E69AD07
P2860
Abnormal priming of CD4(+) T cells by dendritic cells expressing hepatitis C virus core and E1 proteins.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
name
Abnormal Priming of CD4+ T Cel ...... s C Virus Core and E1 Proteins
@nl
Abnormal priming of CD4(+) T c ...... C virus core and E1 proteins.
@ast
Abnormal priming of CD4(+) T c ...... C virus core and E1 proteins.
@en
type
label
Abnormal Priming of CD4+ T Cel ...... s C Virus Core and E1 Proteins
@nl
Abnormal priming of CD4(+) T c ...... C virus core and E1 proteins.
@ast
Abnormal priming of CD4(+) T c ...... C virus core and E1 proteins.
@en
prefLabel
Abnormal Priming of CD4+ T Cel ...... s C Virus Core and E1 Proteins
@nl
Abnormal priming of CD4(+) T c ...... C virus core and E1 proteins.
@ast
Abnormal priming of CD4(+) T c ...... C virus core and E1 proteins.
@en
P2093
P2860
P50
P1433
P1476
Abnormal priming of CD4(+) T c ...... s C virus core and E1 proteins
@en
P2093
Ascensión López-Díaz de Cerio
Francisco Borrás-Cuesta
Noelia Casares
Pablo Labarga
P2860
P304
P356
10.1128/JVI.76.10.5062-5070.2002
P577
2002-05-01T00:00:00Z